Publications by authors named "Yuichiro Imamura"

Claim this Profile
S
Structure-based design, synthesis, and evaluation of tetrahydrotriazolothiazepine derivatives as novel 11β-hydroxysteroid dehydrogenase type 1 inhibitors.
Yukinobu Numata, Toru Hasegawa, Makoto Mori, Tsuyoshi Shinozuka, Yuko Yamamoto, Yuichiro Imamura

Bioorg Med Chem· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Erectile dysfunction in young patients and elderly patients by sexual encounter profile: A comparative study.
Motoki Yamagishi, Yuta Ogushi, Ayana Niikura, Tomoka Ohta, Yuki Ichimura, Yuichiro Imamura

Int J Urol· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Investigation of Endogenous Compounds Applicable to Drug-Drug Interaction Studies Involving the Renal Organic Anion Transporters, OAT1 and OAT3, in Humans.
Yuri Tsuruya, Koji Kato, Yamato Sano, Yuichiro Imamura, Kazuya Maeda

Drug Metab Dispos· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Novel Selective Prostaglandin E2 Synthesis Inhibitor Relieves Pyrexia and Chronic Inflammation in Rats.
Ryusuke Sugita, Harumi Kuwabara, Kotaro Sugimoto, Kazufumi Kubota, Yuichiro Imamura

Inflammation· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[INITIAL EXPERIENCE OF THE ENZALUTAMIDE TREATMENT FOR CASTRATION-RESISTANT PROSTATE CANCER].
Atsushi Igarashi, Takashi Fukagai, Masashi Morita, Keiichiro Hayashi, Atsushi Koshikiya, Yuichiro Imamura

Nihon Hinyokika Gakkai Zasshi· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
6
6β-Hydroxycortisol is an endogenous probe for evaluation of drug-drug interactions involving a multispecific renal organic anion transporter, OAT3/SLC22A8, in healthy subjects.
Yuichiro Imamura, Yuri Tsuruya, Katja Damme, Dominik Heer, Yuji Kumagai

Drug Metab Dispos· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of the fluoroquinolone antibacterial agent DX-619 on the apparent formation and renal clearances of 6β-hydroxycortisol, an endogenous probe for CYP3A4 inhibition, in healthy subjects.
Yuichiro Imamura, Nobuyuki Murayama, Noriko Okudaira, Atsushi Kurihara, Katsuhisa Inoue

Pharm Res· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validation studies on blood collection from the jugular vein of conscious mice.
Yasufumi Shirasaki, Yoshihiro Ito, Miho Kikuchi, Yuichiro Imamura, Toshiaki Hayashi

J Am Assoc Lab Anim Sci· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Helicobacter pylori eradication by sitafloxacin-lansoprazole combination and sitafloxacin pharmacokinetics in Mongolian gerbils and its in vitro activity and resistance development.
Tatsuo Yamamoto, Tomomi Takano, Wataru Higuchi, Akihito Nishiyama, Ikue Taneike, Yuichiro Imamura

Antimicrob Agents Chemother· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Functional characterization of multidrug and toxin extrusion protein 1 as a facilitative transporter for fluoroquinolones.
Kin-ya Ohta, Yuichiro Imamura, Noriko Okudaira, Ryou Atsumi, Katsuhisa Inoue

J Pharmacol Exp Ther· February 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MexAB-OprM specific efflux pump inhibitors in Pseudomonas aeruginosa. Part 7: highly soluble and in vivo active quaternary ammonium analogue D13-9001, a potential preclinical candidate.
Ken-Ichi Yoshida, Kiyoshi Nakayama, Masami Ohtsuka, Noriko Kuru, Yoshihiro Yokomizo, Yuichiro Imamura

Bioorg Med Chem· November 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis